Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Iron overload due to red blood cell (RBC) transfusions is associated with morbidity and mortality in lower-risk myelodysplastic syndrome (MDS) patients. Many studies have suggested improved survival after iron chelation therapy (ICT), but valid data are limited. The aim of this study was to assess t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeks, Marlijn, Yu, Ge, Langemeijer, Saskia, Crouch, Simon, de Swart, Louise, Fenaux, Pierre, Symeonidis, Argiris, Čermák, Jaroslav, Hellström-Lindberg, Eva, Sanz, Guillermo, Stauder, Reinhard, Holm, Mette Skov, Mittelman, Moshe, Mądry, Krzysztof, Malcovati, Luca, Tatic, Aurelia, Almeida, Antonio Medina, Germing, Ulrich, Savic, Aleksandar, Šimec, Njetočka Gredelj, Culligan, Dominic, Itzykson, Raphael, Guerci-Bresler, Agnes, Slama, Borhane, Droste, Jackie, van Marrewijk, Corine, van de Loosdrecht, Arjan, Blijlevens, Nicole, van Kraaij, Marian, Bowen, David, de Witte, Theo, Smith, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049356/
https://www.ncbi.nlm.nih.gov/pubmed/31278207
http://dx.doi.org/10.3324/haematol.2018.212332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049356/
https://www.ncbi.nlm.nih.gov/pubmed/31278207
http://dx.doi.org/10.3324/haematol.2018.212332

Ejemplares similares